News for Omnicell, Inc. (OMCL)

On May 23, 2025, Wells Fargo analyst Stan Berenshteyn provided an update on Omnicell (OMCL), a company listed on NASDAQ. The firm has maintained its "Overweight

On May 23, 2025, B of A Securities announced an adjustment to the price target for Omnicell (OMCL), raising it from $30.00 to $34.00. This represents a 13.33% i

Investment firm Piper Sandler has increased its price target for Omnicell (OMCL) from $46 to $57. The firm maintains an Overweight rating on the company's share

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Advance Auto Parts, Inc. AAP rose sharply during Thursday’s ...

Omnicell (OMCL) has revised its financial expectations for the second quarter of 2025. The company now anticipates quarterly revenue to be between $270 million

Omnicell, Inc. (OMCL) has announced the approval of a new stock repurchase initiative valued at $75 million, sanctioned by the company's board of directors. Thi

Omnicell (OMCL) has adjusted its financial outlook for the fiscal year 2025 in response to recent changes in Chinese tariff rates. The company now projects reve

Omnicell, Inc. (NASDAQ:OMCL) (”œOmnicell,” ”œwe,” ”œour,” ”œus,” ”œmanagement,” or the ”œCompany”), a leader in transforming the pharmacy and

Omnicell, Inc. (OMCL) updates its second quarter and full-year 2025 financial outlook, forecasting improved Non-GAAP EBITDA and earnings per share due to red

Omnicell (OMCL) on Thursday raised its adjusted profit outlook for the second quarter and reported the authorization of a new $75 million stock repurchase program, sending shares up 4% in early trading.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Tech-driven gains led by Nvidia (NVDA): Nvidia’s 5.63% surge, fueled by a deal to supply 18,000 AI chips to Saudi Arabia, propelled a 2% rise in the tech sector, boosting S&P 500 futures by 0.24% to 5,918.50 and Nasdaq 100 futures by 0.38% to 21,349.75. Blue-chip resilience amid tariff concerns:…

Omnicell, Inc. (NASDAQ:OMCL) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsKathleen Nemeth - SVP, IRRandall Lipps - Founder,...

Omnicell, Inc. (OMCL) has reaffirmed its revenue expectation for the fiscal year 2025 to be between $1.105 billion and $1.155 billion, aligning with the market

Omnicell (OMCL) has announced its first-quarter revenue of $270 million, surpassing the market consensus of $259.97 million. The company attributes this financi

Omnicell's Q1 Non-GAAP earnings surpass expectations with a notable revenue increase. Analysts predict a potential 73.83% upside, with price targets ran

Omnicell, Inc. (NASDAQ:OMCL) (”œOmnicell,” ”œwe,” ”œour,” ”œus,” ”œmanagement,” or the ”œCompany”), a leader in transforming the pharmacy and

Revenue: Achieved $270 million, surpassing the estimated $260 million and marking a 10% increase from the previous year.GAAP Net Loss: Reported a net loss of $

Omnicell's Q1 earnings beat estimates with $0.26 EPS and $269.67M revenue.